Serum Institute to stockpile Novavax vaccine candidate from around April

"Upwards of 40-50 million doses per month is what we are trying to stockpile starting from April," he said.

The Serum Institute of India, the world's biggest vaccine maker, will start stockpiling millions of doses of the Novavax coronavirus vaccine candidate starting around April, CEO Adar Poonawalla told the Reuters Next conference on Thursday.

Vials of Covishield before being packaged a lab of Serum Institute of India, in Pune. (File photo)

"Upwards of 40-50 million doses per month is what we are trying to stockpile starting from April," he said.